Key findings• This study investigated the U-shaped nonlinear relationship between admission oxygen saturation (SpO2) and ...

University at Buffalo School of Nursing researchers have identified a new benefit of mindfulness for people managing chronic ...

The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...

Study cohort began collecting data on newborns through adulthood, and may offer objective clues on asthma and COPD disease ...

Many Part D prescription drug plans cover Trelegy Ellipta, but costs can vary by plan type and insurer. Read more.

Genetic risk scoring improves COPD detection beyond traditional methods, enabling earlier diagnosis and better patient ...

Led by Tania T. Von Visger, PhD, and Yu-Ping Chang, PhD, the study surveyed 339 adults with COPD. Participants who practice ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

Introducing the AVIEW lineup specialized in simultaneous diagnosis and analysis of thoracic diseases ...

Indian insurers are considering making New Delhi residents pay 10% to 15% more for new health policies after an extraordinary ...

GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...

(Alliance News) - GSK PLC on Thursday said its monoclonal antibody Nucala, also known as mepolizumab, has been accepted for review in China.